Metharbital

Metharbital
Systematic (IUPAC) name
5,5-Diethyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
Clinical data
AHFS/Drugs.com monograph
Legal status
Legal status
Identifiers
CAS Number 50-11-3 YesY
ATC code N03AA30 (WHO)
PubChem CID 4099
IUPHAR/BPS 7230
DrugBank DB00463 YesY
ChemSpider 3957 YesY
UNII 02OS7K758T YesY
KEGG D01382 YesY
ChEMBL CHEMBL450 YesY
Synonyms Endiemal, metharbitone, methobarbitone[1]
Chemical data
Formula C9H14N2O3
Molar mass 198.219 g/mol
  (verify)

Metharbital was patented in 1905 by Emil Fischer working for Merck.[2] It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy.[3][4] It has similar properties to phenobarbital.

History

Synthesis

Metharbital can be synthesized from 2,2-diethylmalonic acid and O-methylisourea.[5][6][7]

References

  1. The Comparative Toxicogenomics Database: Metharbital
  2. US Patent 782742
  3. The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8
  4. The Medical Treatment of Epilepsy by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5
  5. A. Halpern, J.W. Jones, J. Am. Pharm. Assoc., 38, 352 (1949)
  6. Snyder, J. A.; Link, K. P. (1953). "Preparation and Characterization by Alkaline Methanolysis of 5,5-Diethyl-4-(tetraacetyl-β-D-glucosyloxy)-2,6(1,5)-pyrimidinedione". Journal of the American Chemical Society 75 (8): 1881. doi:10.1021/ja01104a030.
  7. U.S. Patent 782,742


This article is issued from Wikipedia - version of the Wednesday, April 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.